Erin McEvoy

Recently, the Cannabis Nurses Network held their 2022 nurse appreciation celebration virtually. Events included an expo hall, a year in review, educational sessions and networking, and the awards ceremony.

Brittany Griner had been arrested in Moscow, Russia and sentenced to prison for cannabis possession, which is illegal in Russia.

On December 2nd, 2022, President Joe Biden signed the Medical Marijuana and Cannabidiol Research Expansion Act, the first piece of standalone cannabis legislation in US history to become law. It will reportedly streamline a new process for cannabis research applications and for manufacturing products for drug development and allow for a larger amount of legal cannabis for research purposes.

In partnership with the Cannabis Center of Excellence, MCR Labs Massachusetts held their second “Cannabis Science Fair” on the afternoon of December 3rd, 2022, as the final event of their Science Over Stigma campaign.

In their 2022 Census of Agriculture, the US Department of Agriculture will, for the first time, collect and publish data on farmers and producers who grow hemp for fabric, food products, and cannabidiol (CBD).

In this recent interview, Bruce Kendall and Dr. Hinanit Koltai of the Volcani Institute share the inspiring story of the late Michelle Kendall and how her passion for science and research brought them all together to study medical cannabis as a potential treatment for ovarian cancer.

The Cannabis & Me research study will reportedly study the effects of cannabis on the human brain, particularly in terms of a user’s prior psychological conditions.

Due to inflation and rising costs of living, Leaf411 resumed its affordability program to address the needs of patients seeking medical cannabis.

International company PQE Group announced in late October their first ever start-up to provide support for medical cannabis.

For the first time, the Association of Official Analytical Collaboration (AOAC) INTERNATIONAL Research Institute granted its Reviewed and Recognized certification to a cannabis potency testing laboratory.

Rylie Maedler shares her amazing journey from pediatric patient to teenage advocate. As a child, she was diagnosed with a rare form of cancer with a high recurrence rate and, through treatment with cannabis, is now in remission. Here, she shares her incredible story to change laws and hearts with her powerful message.

Earlier this month, Committee D37 on Cannabis, a committee within ASTM International, released descriptions of their four new standards for cannabis testing and who they will benefit within the industry.

Research sponsored by biopharmaceutical drug development company Gb Sciences Inc. identified and validated mixtures of cannabis-inspired compounds for the treatment of Parkinson's disease.

The 2022 Canna Pharma Conference was held October 12-13 in San Diego, California.

Kevin McKernan, Chief Scientific Officer and Founder of Medicinal Genomics, shares some insight behind his recently published paper related to cannabis trichomes and positive results on rapid yeast and mold plates.

The Association of Official Analytical Collaboration (AOAC) INTERNATIONAL announced the winners of more than a dozen awards presented at their Annual Meeting.

In this video interview, Dr. Dustin Sulak of Healer.com and Integr8 Health shares his experience with older patients and women who are interested in medical cannabis or psychedelics.

In this video interview, Dr. Dustin Sulak of Healer.com and Integr8 Health shares what he hopes to see happen in the future for patients interested in medical cannabis and psychedelics.

In this video interview, Dr. Dustin Sulak of Healer.com and Integr8 Health shares the most surprising results and quality of treatment response he sees when treating his patients with medical cannabis and psychedelics.

On September 7th, 2022, the Cannabis Center of Excellence (CCOE), Undoo, LLC, and Patriots Helping Vets launched a new national research project for US military veterans to study the efficacy of three products that address the after-effects of cannabis usage.

In this video interview, Dr. Dustin Sulak of Healer.com and Integr8 Health shares the biggest challenge he encounters when educating other healthcare professionals on medical cannabis, both in the past and today.

Recently, some major food and beverage companies expressed interest in selling products containing cannabidiol (CBD), but the Food and Drug Administration (FDA) have not indicated any regulatory progress.

Cannabis Science Conference East was held in Baltimore, Maryland from September 14-16, 2022. Here we provide a few highlights from the event.

In a presentation for the psychedelics track at Cannabis Science Conference East 2022, Janie Maedler, Vice President of Rylie’s Smile Foundation and President of Rylie’s Sunshine LLC, led a panel discussion with Rylie Maedler, President of Rylie’s Smile and CEO of Rylie’s Sunshine LLC; Rita Lynn Lawrence, a cannabis patient advocate; and University of Miami cannabis epidemiologist Dr. Denise Vidot. The presentation titled “Psychedelics for Beginners” discussed the basics of using psychedelics for treating mental health issues safely and successfully. Here are some highlights from the session.

Dr. Dustin Sulak of Healer.com and Integr8 Health shares some insights from two talks he gave at Cannabis Science Conference East 2022.

In his presentation for the psychedelics track at Cannabis Science Conference East 2022, James Schwartz, BSN, LNC, presented “A New Beginning for an Old Therapy: Case Series Review on the Treatment of PTSD and Other Psychiatric Disorders with Psilocybin and Other Psychedelics.” He reviewed the current research and clinical trials studying the effects of psilocybin, plus side effects, potential uses, latest trends, disorders currently being studied, and potential future applications. Schwartz was a trauma trained nurse who worked in the Trauma/Critical Care ICU at Oregon Health and Science University. He is an experienced medical legal consultant and CEO of Cascade High. Here are some highlights from his session.

In his keynote address for the psychedelics track at Cannabis Science Conference East 2022, Dr. Matthew Johnson presented his talk “Psilocybin in the Treatment of Tobacco Addiction,” which reviewed the treatment of substance use disorders with classic psychedelics (5HT2A agonists) including LSD and psilocybin. Dr. Matthew Johnson, PhD, is the Susan Hill Ward Professor of Psychedelics at Johns Hopkins and is one of the world’s most widely published experts on psychedelics. Here are some highlights from his session.

In a keynote address for the psychedelics track at Cannabis Science Conference East 2022, Dr. Andrew Coop, Dr. Chad Johnson, and Dr. Leah Sera of the University of Maryland School of Pharmacy presented “There’S Room for Everyone: The Emerging Field of Psychedelic Therapeutics.” The talk focused on the history of psychedelics, “classical” and “nonclassical” psychedelics, the current clinical research studies on psychedelics, and the announcement of a master’s program in the Cannabis Science and Therapeutics program at the University of Maryland School of Pharmacy. Here are some highlights from the session.

Dr. Anthony Macherone of Agilent Technologies discusses some of the unique challenges when developing testing methods for cannabis products.

Dr. Anthony Macherone of Agilent Technologies shares some insights from his talk at Cannabis Science Conference East 2022.